Pioneering Medicines, Flagship Pioneering’s in house drug discovery
and development unit, is dedicated to conceiving and developing a broad
portfolio of life-changing treatments for patients built from Flagship’s
innovative platforms. Harnessing the drug development expertise of its
team together with the power of Flagship’s multiple scientific platforms,
Pioneering Medicines explores and identifies new product concepts and
then works jointly with Flagship’s companies to form integrated teams
that advance medicines through robust discovery and early clinical
development.
Pioneering Medicines also partners with external collaborators across
biopharma throughout the R&D process, applying its unique approach to
the R&D priorities of partners through highly co-creative relationships.
The team leads Flagship’s Innovation Supply Chain Partnerships with
Novo Nordisk and Pfizer to speed innovation in drug development and
bring novel therapies to patients, as well as a partnership with the Cystic
Fibrosis Foundation to develop therapeutics that address the unmet
needs of people living with cystic fibrosis.
Company Details
Pioneering Medicines Questions
Pioneering Medicines's website is https://www.flagshippioneering.com/pioneering-medicines
Pioneering Medicines's LinkedIn profile is https://www.linkedin.com/company/pioneeringmedicines
Pioneering Medicines has
120 employees.
View email and phone details for 120
employees at Pioneering Medicines.
Pioneering Medicines's industry is
Biotechnology Research
Pioneering Medicines's top competitors are
Boston Bioproducts,
Fable Therapeutics,
Nvelop Therapeutics,
Delphia Therapeutics,
Tessera Therapeutics,
Kalvista Pharmaceuticals, Inc.,
Quiver Bioscience,
Nuvalent, Inc.,
Arena Bioworks,
Myrobalan Therapeutics.
Pioneering Medicines's categories are Biotechnology Research
Pioneering Medicines's founding year is 2020
